KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Long-Term Investments (2016 - 2025)

Precigen (PGEN) has disclosed Long-Term Investments for 12 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Investments changed N/A to $2.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.5 million, a N/A change, with the full-year FY2021 number at $48.6 million, changed N/A from a year prior.
  • Long-Term Investments was $2.5 million for Q3 2025 at Precigen, up from $750000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $103.6 million in Q1 2021 to a low of $750000.0 in Q1 2025.
  • A 4-year average of $33.6 million and a median of $11.9 million in 2022 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: skyrocketed 19759.35% in 2021, then plummeted 86.07% in 2022.
  • Precigen's Long-Term Investments stood at $48.6 million in 2021, then crashed by 75.54% to $11.9 million in 2022, then tumbled by 55.62% to $5.3 million in 2023, then plummeted by 52.42% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Long-Term Investments are $2.5 million (Q3 2025), $750000.0 (Q1 2025), and $5.3 million (Q3 2023).